Modelling the transport of nanoparticles under blood flow using an agent-based approach

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Fullstone, Gavin ^a,c   Wood, Jonathan ^b   Holcombe, Mike ^c   Battaglia, Giuseppe ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

CIRCULATION; ERYTHROCYTE; HUMAN; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; BLOOD CIRCULATION; ERYTHROCYTES; HUMANS; NANOPARTICLES;

EID: 84931275692     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10649     Document Type: Article

References (44)

1. Moghimi, S. M., Hunter, A. C. & Murray, J. C. Long-circulating and target-specifc nanoparticles: Teory to practice. Pharmacol. Rev. 53, 283-318 (2001).
2. Davis, M. E., Chen, Z. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771-782, doi:10.1038/nrd2614 (2008).
3. Zhang, L. et al. Nanoparticles in medicine: Terapeutic applications and developments. Clin. Pharmacol. Ter. 83, 761-769, doi:10.1038/sj.clpt.6100400 (2008).
4. Ginzburg, V. V. & Balijepailli, S. Modeling the thermodynamics of the interaction of nanoparticles with cell membranes. Nano Lett. 7, 3716-3722, doi:10.1021/nl072053l (2007).
5. Lin, J. Q., Zhang, H. W., Chen, Z. & Zheng, Y. G. Penetration of Lipid Membranes by Gold Nanoparticles: Insights into Cellular Uptake, Cytotoxicity, and Teir Relationship. ACS Nano 4, 5421-5429, doi:10.1021/nn1010792 (2010).
6. Decuzzi, P. & Ferrari, M. Te adhesive strength of non-spherical particles mediated by specifc interactions. Biomaterials 27, 5307-5314, doi:10.1016/j.biomaterials.2006.05.024 (2006).
7. Ma, D.-L. et al. Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library. Chem. Commun. 50, 13885-13888, doi:10.1039/c4cc04498c (2014).
8. Chan, D. S.-H. et al. Structure-Based Discovery of Natural-Product-like TNF-α Inh ibitors. Angew. Chem. Int. Ed. 49, 2860-2864, doi:10.1002/anie.200907360 (2010).
9. Sato, H. et al. Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure-Activity Relationships, and Molecular Modeling Studies. J. Med. Chem. 51, 1831-1841, doi:10.1021/jm7015864 (2008).
10. Speck-Planche, A., Kleandrova, V. V., Luan, F. & Cordeiro, M. N. l. D. S. Rational drug design for anti-cancer chemotherapy: Multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents. Bioorgan. Med. Chem. 20, 4848-4855, doi:doi:10.1016/j.bmc.2012.05.071 (2012).
11. Obiol-Pardo, C., Gomis-Tena, J., Sanz, F., Saiz, J. & Pastor, M. A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity. J. Chem. Inf. Model. 51, 483-492, doi:10.1021/ci100423z (2011).
12. Hauke, G. & Hughes, T. J. R. A Unifed Approach to Compressible and Incompressible Flows. Comput. Method. Appl. M. 113, 389-395, doi:10.1016/0045-7825(94)90055-8 (1994).
13. Shojima, M. et al. Magnitude and role of wall shear stress on cerebral aneurysm-Computational fuid dynamic study of 20 middle cerebral artery aneurysms. Stroke 35, 2500-2505, doi:10.1161/01.STR.0000144648.89172.of (2004).
14. Steinman, D. A. Image-based computational fuid dynamics modeling in realistic arterial geometries. Ann. Biomed. Eng. 30, 483-497, doi:10.1114/1.1467679 (2002).
15. Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors afecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515, doi:10.1021/mp800051m (2008).
16. McWhirter, J. L., Noguchi, H. & Gompper, G. Deformation and clustering of red blood cells in microcapillary fows. Sof Matter 7, 10967-10977, doi:10.1039/c1sm05794d (2011).
17. Skalak, R. & Branemar.Pi. Deformation of Red Blood Cells in Capillaries. Science 164, 717-&, doi:10.1126/science.164.3880.717 (1969).
18. McWhirter, J. L., Noguchi, H. & Gompper, G. Flow-induced clustering and alignment of vesicles and red blood cells in microcapillaries. Proc. Natl. Acad. Sci. U.S.A 106, 6039-6043, doi:10.1073/pnas.0811484106 (2009).
19. Schmid-Schönbein.H, Wells, R. & Goldston.J. Infuence of Deformability of Human Red Cells upon Blood Viscosity. Circ. Res. 25, 131-& (1969).
20. Wells, R. E. & Merrill, E. W. Infuence of Flow Properties of Blood upon Viscosity-Hematocrit Relationships. J. Clin. Invest. 41, 1591-&, doi:10.1172/jci104617 (1962).
21. Zhang, J., Johnson, P. C. & Popel, A. S. Red blood cell aggregation and dissociation in shear fows simulated by lattice Boltzmann method. J. Biomech. 41, 47-55, doi:10.1016/j.jbiomech.2007.07.020 (2008).
22. Kaoui, B., Biros, G. & Misbah, C. Why Do Red Blood Cells Have Asymmetric Shapes Even in a Symmetric Flow? Phys. Rev. Lett. 103, doi:10.1103/PhysRevLett.103.188101 (2009).
23. Fedosov, D. A., Peltomaeki, M. & Gompper, G. Deformation and dynamics of red blood cells in fow through cylindrical microchannels. Sof Matter 10, 4258-4267, doi:10.1039/c4sm00248b (2014).
24. Cedervall, T. et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and afnities of proteins for nanoparticles. Proc. Natl. Acad. Sci. 104, 2050-2055, doi:10.1073/pnas.0608582104 (2007).
25. Lundqvist, M. et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. 105, 14265-14270, doi:10.1073/pnas.0805135105 (2008).
26. Vittaz, M. et al. Efect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials 17, 1575-1581, doi:doi:10.1016/0142-9612(95)00322-3 (1996).
27. Otsuka, H., Nagasaki, Y. & Kataoka, K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 55, 403-419, doi:10.1016/s0169-409x(02)00226-0 (2003).
28. Owens, D. E. & Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93-102, doi:10.1016/j.ijpharm.2005.10.010 (2006).
29. Chambers, E. & Mitragotri, S. Long circulating nanoparticles via adhesion on red blood cells: Mechanism and extended circulation. Exp. Biol. Med. 232, 958-966 (2007).
30. van den Berg, B. M., Vink, H. & Spaan, J. A. E. Te endothelial glycocalyx protects against myocardial edema. Circ. Res. 92, 592-594, doi:10.1161/01.res.0000065917.53950.75 (2003).
31. Tan, J., Tomas, A. & Liu, Y. Infuence of red blood cells on nanoparticle targeted delivery in microcirculation. Sof Matter 8, 1934-1946, doi:10.1039/c2sm06391c (2012).
32. Bogdanov, A. et al. A long-circulating co-polymer in "passive targeting" to solid tumors. J. Drug Target. 4, 321-330, doi:10.3109/10611869708995848 (1997).
33. Iyer, A. K., Khaled, G., Fang, J. & Maeda, H. Exploiting the enhanced permeability and retention efect for tumor targeting. Drug Discov. Today 11, 812-818, doi:10.1016/j.drudis.2006.07.005 (2006).
34. Maeda, H., Wu, J., Sawa, T., Matsumura, Y. & Hori, K. Tumor vascular permeability and the EPR efect in macromolecular therapeutics: a review. J. Control. Release 65, 271-284, doi:10.1016/s0168-3659(99)00248-5 (2000).
35. Fang, J., Nakamura, H. & Maeda, H. Te EPR efect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the efect. Adv. Drug Deliv. Rev. 63, 136-151, doi:10.1016/j.addr.2010.04.009 (2011).
36. Pegoraro, C. et al. Translocation of fexible polymersomes across pores at the nanoscale. Biomater. Sci. 2, 680-692, doi:10.1039/c3bm60294j (2014).
37. Cevc, G. & Gebauer, D. Hydration-Driven Transport of Deformable Lipid Vesicles through Fine Pores and the Skin Barrier. Biophys. J. 84, 1010-1024 (2003).
38. Sugahara, K. N. et al. Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors. Cancer Cell 16, 510-520, doi:10.1016/j.ccr.2009.10.013 (2009).
39. Sugahara, K. N. et al. Co-administration of a Tumor-Penetrating Peptide Enhances the Efcacy of Cancer Drugs. Science (New York, N.Y.) 328, 1031-1035, doi:10.1126/science.1183057 (2010).
40. Andrews, S. S. & Bray, D. Stochastic simulation of chemical reactions with spatial resolution and single molecule detail. Phys. Biol. 1, 137-151, doi:10.1088/1478-3967/1/3/001 (2004).
41. Knop, R. Remark on algorithm 334 [G5]: normal random deviates. Commun. ACM 12, 281, doi:10.1145/362946.362996 (1969).
42. Box, G. E. P. & Muller, M. E. A Note on the Generation of Random Normal Deviates. Ann. Math. Statist. 29, 610-611, doi:10.1214/aoms/1177706645 (1958).
43. Milici, A. J., Lhernault, N. & Palade, G. E. Surface Densities of Diaphragmed Fenestrae and Transendothelial Channels in Diferent Murine Capillary Beds. Circ. Res. 56, 709-717 (1985).
44. Glantz, S. Primer of Biostatistics. (McGraw-Hill Medical, 2005).